Balance Sheet: Liabilities and Stockholders’ Equity

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Johnson & Johnson, consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

	Dec 29, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Loans and notes payable	5,983)	3,451)	12,771)	3,766)	2,631)
Accounts payable	10,311)	9,632)	11,703)	11,055)	9,505)
Accrued liabilities	8,549)	10,212)	11,456)	13,612)	13,968)
Accrued rebates, returns and promotions	17,580)	16,001)	14,417)	12,095)	11,513)
Accrued compensation and employee related obligations	4,126)	3,993)	3,328)	3,586)	3,484)
Accrued taxes on income	3,772)	2,993)	2,127)	1,112)	1,392)
Current liabilities	50,321)	46,282)	55,802)	45,226)	42,493)
Long-term debt, excluding current portion	30,651)	25,881)	26,888)	29,985)	32,635)
Deferred taxes on income	2,448)	3,193)	6,374)	7,487)	7,214)
Employee related obligations	7,255)	7,149)	6,767)	8,898)	10,771)
Long-term taxes payable	390)	2,881)	4,306)	5,713)	6,559)
Other liabilities	17,549)	13,398)	10,437)	10,686)	11,944)
Non-current liabilities	58,293)	52,502)	54,772)	62,769)	69,123)
Total liabilities	108,614)	98,784)	110,574)	107,995)	111,616)
Preferred stock, without par value, unissued	—)	—)	—)	—)	—)
Common stock, par value $1.00 per share	3,120)	3,120)	3,120)	3,120)	3,120)
Accumulated other comprehensive loss	(11,741)	(12,527)	(12,967)	(13,058)	(15,242)
Retained earnings and Additional-paid-in-capital	155,791)	153,843)	128,345)	123,060)	113,890)
Common stock held in treasury, at cost	(75,680)	(75,662)	(41,694)	(39,099)	(38,490)
Shareholders’ equity	71,490)	68,774)	76,804)	74,023)	63,278)
Total liabilities and shareholders’ equity	180,104)	167,558)	187,378)	182,018)	174,894)

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Loans and notes payable: The values show notable volatility, peaking significantly at 12,771 million in 2022 before decreasing to 3,451 million in 2023 and rising again to 5,983 million in 2024.
Accounts payable: There is a gradual increase from 9,505 million in 2020 to a peak of 11,703 million in 2022, followed by a decline in 2023 and a moderate recovery in 2024.
Accrued liabilities: These liabilities show a continuous downward trend over the period, decreasing from 13,968 million in 2020 to 8,549 million in 2024.
Accrued rebates, returns and promotions: A consistent upward trend is observed, increasing steadily from 11,513 million in 2020 to 17,580 million in 2024.
Accrued compensation and employee related obligations: These obligations fluctuate moderately, starting at 3,484 million in 2020, dipping slightly through 2022, and rising to a peak of 4,126 million in 2024.
Accrued taxes on income: A marked increase occurs, nearly tripling from 1,392 million in 2020 to 3,772 million in 2024, indicating higher tax liabilities over time.
Current liabilities: Current liabilities show variability with an increase from 42,493 million in 2020 to a peak at 55,802 million in 2022, then a drop to 46,282 million in 2023, followed by a rise to 50,321 million in 2024.
Long-term debt, excluding current portion: There is a decreasing trend from 32,635 million in 2020 to 25,881 million in 2023, but the level increases again to 30,651 million in 2024.
Deferred taxes on income: A steady decline is observed, from 7,214 million in 2020 to 2,448 million in 2024, suggesting a reduction in deferred tax liabilities.
Employee related obligations: These obligations decrease from 10,771 million in 2020 to 6,767 million in 2022, with minor recovery thereafter, reaching 7,255 million in 2024.
Long-term taxes payable: A significant reduction over the years from 6,559 million in 2020 to only 390 million in 2024, indicating substantial payment or reclassification of tax liabilities.
Other liabilities: An initial decline from 11,944 million in 2020 to 10,437 million in 2022 is followed by a sharp increase to 17,549 million in 2024.
Non-current liabilities: A continuous decrease is noted from 69,123 million in 2020 down to 52,502 million in 2023, with a rebound to 58,293 million in 2024.
Total liabilities: Total liabilities generally decrease from 111,616 million in 2020 to a low of 98,784 million in 2023, then rise to 108,614 million in 2024, reflecting the combined movements in current and non-current components.
Common stock, par value $1.00 per share: No change is observed across the periods, remaining constant at 3,120 million.
Accumulated other comprehensive loss: There is a gradual reduction in the accumulated loss, from -15,242 million in 2020 to -11,741 million in 2024, reflecting an improvement in comprehensive income or changes in components of other comprehensive income.
Retained earnings and Additional-paid-in-capital: A steady and substantial increase is apparent, rising from 113,890 million in 2020 to 155,791 million in 2024, indicating accumulation of profits and capital contributions.
Common stock held in treasury, at cost: Treasury stock shows an increasing cost from -38,490 million in 2020 to a significant increase to -75,680 million in 2024, suggesting substantial stock repurchases over this period.
Shareholders’ equity: Equity increases from 63,278 million in 2020 to 76,804 million in 2022, followed by a decline to 68,774 million in 2023 and a slight recovery to 71,490 million in 2024, indicative of fluctuations in net assets.
Total liabilities and shareholders’ equity: This total mirrors the overall asset base, increasing from 174,894 million in 2020 to 187,378 million in 2022, then declining to 167,558 million in 2023 and rising again to 180,104 million in 2024.

Download chart

Johnson & Johnson (NYSE:JNJ)

Balance Sheet: Liabilities and Stockholders’ Equity